ENPICOM

Attending #PEGSBoston? Make sure to stop by Booth #221 to meet Nicola Bonzanni, Piotr van Rijssel, and Ivan H.. Discover how we can collaborate to fast-track your #drugdiscovery success and don't forget to grab a delicious stroopwafel while you're there! 🍪 Interested in cutting-edge technology for antibody humanization? Visit Poster C093: Genovac OptiAb™ Powered by ENPICOM- A Deep Learning Tool and Service for Next Generation Antibody Humanization See you there! 👋 #deeplearning #antibodies #AI #machinelearning

We're excited to be attending #PEGS24 with the Genovac team this week! Be sure to swing by booth 221 to meet our experts and discuss your antibody discovery challenges and #deeplearning opportunities. Book a session with our experts today: https://lnkd.in/e_qg8Dgr #PEGSBoston #antibodydiscovery #machinelearning #antibodyanalysis

Rise and shine, Boston! 🌞 Genovac’s Pete Leland and ENPICOM’s Nicola Bonzanni will be speaking at #PEGS2024 today at 10:00. Discover how OptiAb™ enables efficient and high throughput humanization of antibodies with high success rates, leading to significant savings in cost and time. Don’t miss out! Can’t make it to the conference? Request the presentation recording here: https://lnkd.in/e_qg8Dgr #pegsboston #partnerships #drugdiscovery #machinelearning

The countdown to the PEGS Boston Summit is on! Join us and Genovac to discover how you can elevate your biologics development with a generative #deeplearning solution. Book a session with our experts today: https://lnkd.in/e_qg8Dgr #pegsboston #partnerships #drugdiscovery #machinelearning

One of the key challenges in leveraging #bigdata in drug discovery is the lack of connectivity between siloed data sources and analytical tools. This is where APIs come in. With an effective and comprehensive #API solution, researchers can seamlessly integrate data from various sources, automate data entry and quality control processes, and leverage #deeplearning models for advanced data analysis. Learn more: https://lnkd.in/edxr7vhw

Data reproducibility and data sharing in immune repertoire research are essential for scientific advancement and collaboration. We spoke with Dr. Felix Breden from Simon Fraser University about the importance of standardized data, challenges in repertoire profiling, and future developments in the field. Check it out: https://lnkd.in/e2F4JqJm #NGS #research #bcells #tcells

Each therapeutic discovery company and research team has its unique workflow that changes over time. If you don't have the flexibility to adjust your data analysis solution to your needs, you may get stuck with outdated technology and inefficient processes, slowing down the discovery process.   Check out our latest blog post where we break down the importance of tailored solutions and how our Last Mile Service can elevate your antibody discovery. https://lnkd.in/e8NQDgGH #drugdiscovery #automation #antibodydiscovery

How can immune repertoire sequencing be applied in vaccine research? 👀 With high-throughput Rep-Seq, you can dive deep into your data and uncover a wealth of insights. From analyzing diversity to tracking clonal expansion & overlap, you'll have the tools to evaluate your vaccine candidates and enhance your vaccine design. Talk to our experts about your project today! https://lnkd.in/esVSSeN7 #vaccineresearch #NGS #drugdiscovery

Are you curious about optimizing bioinformatics tools, algorithms, and pipelines tailored for immune repertoire data analysis? Or maybe you're interested in benchmarking computational tools and identifying optimal strategies for repertoire profiling? 🤔 Check out our recent article for a detailed guide on simulating realistic AIRR sequencing data using InSilicoSeq 2.0: https://lnkd.in/eKDR9fwG If you would like to learn more, you can also read the manuscript available on the BioRXiv preprint server: https://lnkd.in/ekbhQtQY #AIRRSeq #sequencing #bioinformatics #immunerepertoire

Unlock the full potential of your therapeutics discovery journey with ENPICOM’s new Last Mile Service 🚀   The journey to the discovery of successful therapeutics is as unique as your discovery platforms. Introducing our Last Mile Service, a fast and personalized approach to tailor antibody discovery data analysis to your needs.   Whether you need customized reports or bespoke analyses, you can rely on our team’s expertise to get your workflow running. Say goodbye to one-size-fits-all solutions and ensure that your project stays on track and ahead of the competition.   Let’s embark on this journey together. Schedule a meeting to discuss your project today: https://lnkd.in/e-iubdJK #drugdiscovery #customization #automation